Home/Turn Therapeutics/Muhammad Zubair

MZ

Muhammad Zubair

Controller

Turn Therapeutics

Therapeutic Areas

Dermatology Wound Care Infectious Disease

Turn Therapeutics Pipeline

Drug	Indication	Phase
GX-03	Moderate-to-Severe Atopic Dermatitis (Eczema)	Phase 1
Hexagen™ Wound Dressing	Wound Care & Infection Prevention	Commercial
Thermostable Vaccine Initiative	Global Health / Infectious Disease	Research

Leadership Team at Turn Therapeutics

Chief Executive Officer & Founder

Dr. Neil Ghodadra, MD

Chief Medical Officer, Board Director

Zuraiz Chaudhary, CPA

Chief Accounting Officer, VP Finance

View full Turn Therapeutics profile